Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 14,000 shares at $34.24 ($477K) on 2026-02-02, disclosed to the SEC on 2026-02-02.
Seasonal sale ($477k) by EVP R&D, Chief Medical Officer — this insider has traded ALKS in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.54 | 4,000 | $134K | 28.2% |
| 2 | $34.24 | 5,000 | $171K | 35.9% |
| 3 | $34.24 | 5,000 | $171K | 35.9% |
| Total | $34.04 avg | 14,000 | $477K | 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |